International journal of environmental research and public health

revista panamericana de salud publica = pan american journal of public health

Expert review of pharmacoeconomics & outcomes research

preventing chronic disease

[1] Unintended pregnancy and its impact on childhood rotavirus immunization in Peru.

[2] Estimating the money flow in the economy attributed to rotavirus disease and vaccination in the Netherlands using a Social Accounting Matrix (SAM) framework.

[3] Pharmacists in Federally Qualified Health Centers: Models of Care to Improve Chronic Disease.

[4] Pathogen-Specific Impacts of the 2011-2012 La Niña-Associated Floods on Enteric Infections in the MAL-ED Peru Cohort: A Comparative Interrupted Time Series Analysis.

[5] Etiologies, Risk Factors and Impact of Severe Diarrhea in the Under-Fives in Moramanga and Antananarivo, Madagascar

[6] ocorrência de rota vírus e adeno vírus em crianças de até 11 anos de idade sem sintomatologia de diarréia em goiânia - go

[7] cost-effectiveness analysis of rotavirus vaccination among libyan children using a simple economic model

[8] leite de mulheres brasileiras apresenta anticorpos iga secretores (siga) que neutralizam o rotavírus g9p[5]

[9] rotavirus epidemiology before and after vaccine introduction

[10] effect of cell culture system on the production of human viral antigens efeito do sistema de cultura celular na produção de antígenos virais humanos

[11] rotavirus infection and the current status of rotavirus vaccines

[12] the frequency of rotavirus and enteric adenovirus in children with acute gastroenteritis in mardin

[13] infeksi rotavirus pada anak usia di bawah dua tahun

[14] the interactions between host glycobiology, bacterial microbiota, and viruses in the gut

[15] oral administration of a seed-based bivalent rotavirus vaccine containing vp6 and nsp4 induces specific immune responses in mice

[16] molecular characterisation and clinical correlates of rotavirus in children and adults in a tertiary care centre, chennai, south india

[17] Área de ciencias básicas y experimentales: determinación de la función de la proteína vp6 y los péptidos (280-297) de vp6 (530-559) de vp4 en la entrada de rotavirus.

[18] intestinal innate antiviral immunity and immunobiotics: beneficial effects against rotavirus infection

[19] A Cross-Sectional Study of Socio-Demographic Factors and Vaccination Compliance Among Children Under Two in Bhubaneswar, India, With Emphasis on Parental Education.

[20] Further considerations on rotavirus vaccination and seizure-related hospitalization rates

[21] Letter to the editor regarding “Rotavirus infection beyond the gut”

[22] Rotavirus infection beyond the gut

[23] Further considerations on rotavirus vaccination and seizure-related hospitalization rates

[24] Letter to the editor regarding “Rotavirus infection beyond the gut”

[25] Rotavirus infection beyond the gut

[26] Differential and enhanced response to climate forcing in diarrheal disease due to rotavirus across a megacity of the developing world.

[27] Coverage and Determinants of Uptake for Privately Funded Rotavirus Vaccine in a Canadian Birth Cohort, 2008-2013.

[28] Knowledge, attitudes, beliefs, and behaviors of parents and healthcare providers before and after implementation of a universal rotavirus vaccination program.

[29] Association Between Rotavirus Vaccination and Risk of Intussusception Among Neonates and Infants: A Systematic Review and Meta-analysis.

[30] Unintended pregnancy and its impact on childhood rotavirus immunization in Peru.

[31] Estimating the money flow in the economy attributed to rotavirus disease and vaccination in the Netherlands using a Social Accounting Matrix (SAM) framework.

[32] Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules

[33] Enteropathogens and Rotavirus Vaccine Immunogenicity in a Cluster Randomized Trial of Improved Water, Sanitation and Hygiene in Rural Zimbabwe

[34] The Impact of Improved Water, Sanitation, and Hygiene on Oral Rotavirus Vaccine Immunogenicity in Zimbabwean Infants: Substudy of a Cluster-randomized Trial

[35] Longitudinal study of rotavirus C VP6 genotype I6 in diarrheic piglets up to 1 week old.

[36] The Impact of Human Genetic Polymorphisms on Rotavirus Susceptibility, Epidemiology, and Vaccine Take.

[37] Success of rotavirus vaccination in Finland, a register based study measuring impact beyond overall effectiveness

[38] Impact of the Introduction of Rotavirus Vaccine on Hospital Admissions for Diarrhea Among Children in Kenya: A Controlled Interrupted Time-Series Analysis

[39] Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses

[40] RotaC: A web-based tool for the complete genome classification of group A rotaviruses

[41] Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana

[42] Effectiveness of Monovalent Rotavirus Vaccine Against Hospitalization With Acute Rotavirus Gastroenteritis in Kenyan Children

[43] Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda

[44] Comparison of Premier™ Rotaclone®, ProSpecT™, and RIDASCREEN® rotavirus enzyme immunoassay kits for detection of rotavirus antigen in stool specimens

[45] The Pentavalent Rotavirus Vaccine: Discovery to Licensure and Beyond

[46] Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient–Level Costing Data

[47] RotaC: a web-based tool for the complete genome classification of group A rotaviruses

[48] Impact of Rotavirus Vaccine Introduction and Postintroduction Etiology of Diarrhea Requiring Hospital Admission in Haydom, Tanzania, a Rural African Setting

[49] Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana

[50] Global, Regional, and National Estimates of Rotavirus Mortality in Children

[51] Measuring Rotavirus Vaccine Impact in Sub-Saharan Africa

[52] Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes

[53] The Impact of Improved Water, Sanitation, and Hygiene on Oral Rotavirus Vaccine Immunogenicity in Zimbabwean Infants: Substudy of a Cluster-randomized Trial

[54] Use of Patients With Diarrhea Who Test Negative for Rotavirus as Controls to Estimate Rotavirus Vaccine Effectiveness Through Case-Control Studies

[55] Impact of rotavirus vaccination on rotavirus and all-cause gastroenteritis in peri-urban Kenyan children

[56] Global seasonality of rotavirus infections

[57] Health Impact of Rotavirus Vaccination in Developing Countries: Progress and Way Forward

[58] Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda

[59] Monovalent Rotavirus Vaccine Effectiveness and Impact on Rotavirus Hospitalizations in Zanzibar, Tanzania: Data From the First 3 Years After Introduction

[60] Rotavirus vaccines WHO position paper: January 2013 - Recommendations

[61] Impact and effectiveness of pentavalent rotavirus vaccine in children

[62] Distribution of rotavirus strains and strain-specific effectiveness of the rotavirus vaccine after its introduction: a systematic review and meta-analysis

[63] Rotavirus vaccine effectiveness in low-income settings: An evaluation of the test-negative design

[64] Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study

[65] Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study

[66] Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses

[67] [A systematic review of the risk of oral rotavirus vaccine and intussusception]

[68] Impact of Rotavirus Vaccine Introduction and Postintroduction Etiology of Diarrhea Requiring Hospital Admission in Haydom, Tanzania, a Rural African Setting

[69] Use of Patients With Diarrhea Who Test Negative for Rotavirus as Controls to Estimate Rotavirus Vaccine Effectiveness Through Case-Control Studies

[70] Malnutrition levels among vaccinated and unvaccinated children between 2 and 3 years of age following enrollment in a randomized clinical trial with the pentavalent rotavirus vaccine (PRV) in Bangladesh

[71] A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia

[72] Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study

[73] Rotavirus vaccines:an update

[74] Differences of Rotavirus Vaccine Effectiveness by Country: Likely Causes and Contributing Factors

[75] Impact of rotavirus vaccination on rotavirus hospitalisation rates among a resource-limited rural population in Mbita, Western Kenya

[76] Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial

[77] Performance of rotavirus vaccines in developed and developing countries

[78] A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia

[79] Human rotavirus vaccine Rotarix ™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial

[80] Update of rotavirus strains circulating in Africa from 2007 through 2011

[81] Incidence and Clinical Characteristics of Group A Rotavirus Infections among Children Admitted to Hospital in Kilifi, Kenya

[82] High burden of rotavirus gastroenteritis in young children in rural western Kenya, 2010-2011

[83] Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel

[84] Global Review of the Age Distribution of Rotavirus Disease in Children Aged

[85] Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine

[86] Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

[87] Incidence of rotavirus gastroenteritis by age in African, Asian and European children: Relevance for timing of rotavirus vaccination

[88] Global, Regional, and National Estimates of Rotavirus Mortality in Children

[89] Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study

[90] Health Impact of Rotavirus Vaccination in Developing Countries: Progress and Way Forward

[91] Protective action of Bacillus clausii probiotic strains in an in vitro model of Rotavirus infection

[92] full genome characterization of novel ds-1-like g9p[8] rotavirus strains that have emerged in thailand.

[93] construction and analysis of decision-making model in assessing the impact of vaccination with rotavirus vaccine in ukraine

[94] cost-effectiveness analysis of rotavirus vaccination among libyan children using a simple economic model

[95] un modelo del mecanismo de entrada de los rotavirus a la cÉlula hospedera

[96] leite de mulheres brasileiras apresenta anticorpos iga secretores (siga) que neutralizam o rotavírus g9p[5]

[97] rotavirus gastroenteritis and a rare case accompanying acute pancreatitis

[98] features of cellular immunity in children with mono- and mixed rotavirus infection

[99] rotavirus epidemiology before and after vaccine introduction

[100] rotavirus replication and the role of cellular lipid droplets: new therapeutic targets?

[101] no direct correlation between rotavirus diarrhea and breast feeding: a meta-analysis